Brian E. Mcdowell

Array ( [id] => 4676928 [patent_doc_number] => 20080214559 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'COMPOUNDS WITH A COMBINATION OF CANNABINOID CB1 ANTAGONISM AND SEROTONIN REUPTAKE INHIBITION' [patent_app_type] => utility [patent_app_number] => 11/970229 [patent_app_country] => US [patent_app_date] => 2008-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14121 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20080214559.pdf [firstpage_image] =>[orig_patent_app_number] => 11970229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5290980 [patent_doc_number] => 20090023710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Compound' [patent_app_type] => utility [patent_app_number] => 11/968436 [patent_app_country] => US [patent_app_date] => 2008-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 75816 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20090023710.pdf [firstpage_image] =>[orig_patent_app_number] => 11968436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4807825 [patent_doc_number] => 20080171403 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-17 [patent_title] => 'NOVEL COMPOUND AND METHOD OF PRODUCING ORGANIC SEMICONDUCTOR DEVICE' [patent_app_type] => utility [patent_app_number] => 11/964619 [patent_app_country] => US [patent_app_date] => 2007-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 25376 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20080171403.pdf [firstpage_image] =>[orig_patent_app_number] => 11964619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7527452 [patent_doc_number] => 08044044 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-25 [patent_title] => '4-(1-amino-ethyl)-cyclohexylamine derivatives' [patent_app_type] => utility [patent_app_number] => 12/520580 [patent_app_country] => US [patent_app_date] => 2007-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33177 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/044/08044044.pdf [firstpage_image] =>[orig_patent_app_number] => 12520580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6515112 [patent_doc_number] => 20100216767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'QUINAZOLINES FOR PDK1 INHIBITION' [patent_app_type] => utility [patent_app_number] => 12/448390 [patent_app_country] => US [patent_app_date] => 2007-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 114 [patent_figures_cnt] => 114 [patent_no_of_words] => 57308 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216767.pdf [firstpage_image] =>[orig_patent_app_number] => 12448390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7515434 [patent_doc_number] => 08039506 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-18 [patent_title] => 'Bicyclic lactam factor VIIa inhibitors useful as anticoagulants' [patent_app_type] => utility [patent_app_number] => 12/519365 [patent_app_country] => US [patent_app_date] => 2007-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59512 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/039/08039506.pdf [firstpage_image] =>[orig_patent_app_number] => 12519365 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4833999 [patent_doc_number] => 20080132546 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'CHEMICAL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 11/950105 [patent_app_country] => US [patent_app_date] => 2007-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41587 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20080132546.pdf [firstpage_image] =>[orig_patent_app_number] => 11950105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6350876 [patent_doc_number] => 20100249161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => '2- ( 2 -HYDROXYPHENYL) -QUINAZOLIN-4-ONES USEFUL FOR TREATING OBESITY AND DIABETES' [patent_app_type] => utility [patent_app_number] => 12/515051 [patent_app_country] => US [patent_app_date] => 2007-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15088 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20100249161.pdf [firstpage_image] =>[orig_patent_app_number] => 12515051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4894206 [patent_doc_number] => 20080103305 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-01 [patent_title] => 'Process for the preparation of imatinib' [patent_app_type] => utility [patent_app_number] => 11/978227 [patent_app_country] => US [patent_app_date] => 2007-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4185 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20080103305.pdf [firstpage_image] =>[orig_patent_app_number] => 11978227 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4596141 [patent_doc_number] => 07981893 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-19 [patent_title] => 'Heteroaryl compounds, compositions thereof, and methods of treatment therewith' [patent_app_type] => utility [patent_app_number] => 11/975652 [patent_app_country] => US [patent_app_date] => 2007-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 118505 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/981/07981893.pdf [firstpage_image] =>[orig_patent_app_number] => 11975652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6481373 [patent_doc_number] => 20100041884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'CRYSTAL MODIFICATIONS-3-(1H-INDOL-3-YL)-4- [4-METHYL-PIPERAZIN-1-YL)-QUINAZOLIN-4-YL] -PYRROLE-2, 5-D IONE' [patent_app_type] => utility [patent_app_number] => 12/445371 [patent_app_country] => US [patent_app_date] => 2007-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 5547 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20100041884.pdf [firstpage_image] =>[orig_patent_app_number] => 12445371 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5485750 [patent_doc_number] => 20090275515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => '2-HYDROXY-2-PHENYLTHIOPHENYLPROPIONAMIDES AS ANDROGEN RECEPTOR MODULATORS' [patent_app_type] => utility [patent_app_number] => 12/442581 [patent_app_country] => US [patent_app_date] => 2007-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22803 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20090275515.pdf [firstpage_image] =>[orig_patent_app_number] => 12442581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8560313 [patent_doc_number] => 08334377 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-18 [patent_title] => 'Porphyrin catalysts and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/311639 [patent_app_country] => US [patent_app_date] => 2007-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13181 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12311639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8294476 [patent_doc_number] => 08222262 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-17 [patent_title] => 'Indazolyl derivatives useful as potassium channel modulating agents' [patent_app_type] => utility [patent_app_number] => 12/444344 [patent_app_country] => US [patent_app_date] => 2007-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10384 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12444344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6608007 [patent_doc_number] => 20100063275 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'PROCESS FOR PREPARING 6-PHENOXYPYRIMIDIN-4-OL DERIVATIVES IN THE PRESENCE OF A QUINUCLIDINE OR A N-METHYL PYRROLIDINE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/444866 [patent_app_country] => US [patent_app_date] => 2007-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9537 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20100063275.pdf [firstpage_image] =>[orig_patent_app_number] => 12444866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6517944 [patent_doc_number] => 20100261738 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'NOVEL POLYMORPHS OF ERLOTINIB HYDROCHLORIDE AND METHOD OF PREPARATION' [patent_app_type] => utility [patent_app_number] => 12/672191 [patent_app_country] => US [patent_app_date] => 2007-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2157 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20100261738.pdf [firstpage_image] =>[orig_patent_app_number] => 12672191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4553099 [patent_doc_number] => 07820649 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-26 [patent_title] => 'Quinazolinone and isoquinolinone acetamide derivatives' [patent_app_type] => utility [patent_app_number] => 11/852762 [patent_app_country] => US [patent_app_date] => 2007-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28273 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/820/07820649.pdf [firstpage_image] =>[orig_patent_app_number] => 11852762 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9239252 [patent_doc_number] => 08604044 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'Quinazoline based EGFR inhibitors containing a zinc binding moiety' [patent_app_type] => utility [patent_app_number] => 11/852604 [patent_app_country] => US [patent_app_date] => 2007-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 19 [patent_no_of_words] => 54800 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11852604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4786261 [patent_doc_number] => 20080139590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'QUINAZOLINE BASED EGFR INHIBITORS CONTAINING A ZINC BINDING MOIETY' [patent_app_type] => utility [patent_app_number] => 11/852585 [patent_app_country] => US [patent_app_date] => 2007-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 41930 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20080139590.pdf [firstpage_image] =>[orig_patent_app_number] => 11852585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10586602 [patent_doc_number] => 09308198 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-12 [patent_title] => 'Treatment, prevention, and reversal of alcohol-induced brain disease' [patent_app_type] => utility [patent_app_number] => 12/310831 [patent_app_country] => US [patent_app_date] => 2007-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 143 [patent_no_of_words] => 25603 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12310831 [rel_patent_id] =>[rel_patent_doc_number] =>)